Mumbai-based nutrition startup Ace Blend has raised $9.91 million in a Series A2 funding round led by 3one4 Capital, with participation from existing investor Fireside Ventures.
Prior to this, Fireside Ventures had led Ace Blend's $3.3 million pre-Series A round in August 2025.
The startup will use the fresh capital for research-led product development and bring new nutrition formats to market. It claims it grew 300% in FY26, and that more than 46% of its customers come back to buy again.
Founder Shivam Hingorani said the funding will be used to conduct clinical trials through contract research organisations (CROs), with plans to publish the findings in peer-reviewed international journals.
The startup aims to strengthen its supply chain capabilities and develop an automated system to test every batch for nutritional accuracy, pesticide residues and heavy metals without human intervention.
It plans to conduct shelf-stability studies at launch and again six months later, while sourcing raw materials from multiple countries.
Products in development include a formulation made with a gut-health specialist to address leaky gut, a mix of natural nutrients meant to lower inflammation, an eye-health product and a fibre-based format for gut health, Hingorani said.
Ace Blend is targeting annual recurring revenue of Rs 250-300 crore over the next 12-18 months, with profitability also in sight, he added.
Hingorani started selling Ace Blend products in 2018. Saif Mehkri joined as co-founder in 2022, bringing nearly three decades of experience in the nutrition industry.
The startup sells around 14 SKUs, including plant-based protein powders, superfood mixes and functional supplements for heart health, brain health, sleep, recovery, gut health, strength and immunity.
Source link
